Stratasys (SSYS) and Ricoh USA said Wednesday the first patient has been enrolled in a clinical study aimed at assessing the use of 3D printed models for orthopedic oncology.
The study will evaluate the efficacy of patient-specific 3D printed anatomical models for preoperative planning and tumor excision, compared with the current standard of care, which relies only on CT or MRI, the companies said.
The study is expected to run for 12 months and involve up to 150 subjects across three sites, Stratasys and Ricoh said.
Stratasys shares were up 1.7% in recent trading.
Price: 8.28, Change: +0.14, Percent Change: +1.72
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments